Total: $180.3 million

Top 2 drugs
Humira (arthritis): $62 million; Humira (psoriasis): $36.7 million
Androgel: $45.6 million
Watch the Humira TV commercial here >>

One might wonder why a company that has the best-selling drug in the world--and one that is slated to remain the best-selling drug for the next 5 years--would feel the need to spend money advertising it. The reason is that until AbbVie ($ABBV) can push some new drugs out of its pipeline, the company will rise, or fall, on sales of the arthritis drug. Humira generated $9.6 billion in global revenues last year. The advertising must be helping because U.S. sales were up 19% to $2.18 billion in the first half of 2013.


Suggested Articles

Which rollouts might suffer most? Those that treat chronic diseases, require doctors to administer them or face current competition, analysts say.

Novartis and Incyte will put their blockbuster JAK inhibitor into phase 3 clinical trials as a possible treatment for COVID-19, the drugmakers said.

The Cannes Lions canceled its advertising creativity conference for 2020 after media reports that many large ad agencies planned to opt out.